From: MDM2 SNP309, gene-gene interaction, and tumor susceptibility: an updated meta-analysis
First author | Tumor site | 309TT | 309TG | 309GG | |||
---|---|---|---|---|---|---|---|
(reference ) | Â | Case* | Control* | Case* | Control* | Case* | Control* |
Yang M | GCA | 19/61/27 | 96/150/52 | 59/119/72 | 162/222/114 | 45/65/33 | 58/114/32 |
Singh V | BC | 10/11/4 | 4/18/3 | 23/21/4 | 13/32/2 | 13/13/5 | 11/15/7 |
Yoon YJ | HCC | 23/18/4 | 40/38/6 | 48/58/19 | 56/53/23 | 39/35/43 | 28/45/8 |
Xiong XJ | AML | 6/22/4 | 12/17/6 | 29/62/32 | 22/33/13 | 17/43/16 | 5/14/6 |
Zhang X | LC | 62/127/60 | 122/222/74 | 170/259/132 | 223/343/145 | 89/120/87 | 80/166/45 |
Cox DG | BC | 349/218/40 | 488/346/60 | 317/266/45 | 539/365/52 | 104/63/14 | 166/92/10 |